Irazu Oncology

Baltimore, United States

Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients

$500K raised

Mar 2025

Seed

Biopharma Biotechnology Life Science Pharmaceutical

Top Investors

TEDCO

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Irazu Oncology

How much funding has Irazu Oncology raised?

Irazu Oncology has raised $500K in total funding. The most recent round was Seed. The last funding was announced in March 2025.

Who are Irazu Oncology's investors?

Irazu Oncology's investors include TEDCO.

Where is Irazu Oncology headquartered?

Irazu Oncology is headquartered in Baltimore, United States.

What does Irazu Oncology do?

Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients

What stage is Irazu Oncology at?

Irazu Oncology is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 5, 2025.

MLA

"Irazu Oncology — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/irazu-oncology. Accessed June 4, 2026.

APA

VCBacked. (2025). Irazu Oncology — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/irazu-oncology

Wikipedia (cite web)

{{cite web |title=Irazu Oncology — Funding & Investors |url=https://www.vcbacked.co/company/irazu-oncology |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 5, 2025.

Similar Companies in Biopharma